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In Brief 38 
Salmonella infection can no longer be controlled in mice lacking pyroptosis, apoptosis 39 
and necroptosis. Doerflinger et al. demonstrates that these cell death pathways are highly 40 
interconnected and used very flexibly. Furthermore, it is demonstrated that the initiators 41 
of pyroptosis and extrinsic apoptosis Caspase-1 and -8, respectively, can exert executioner 42 





• Combined deletion of pyroptosis, apoptosis and necroptosis in mice leads to a 48 
failure to control Salmonella infection.  49 
• BMDMs lacking caspase-1/11/12/8 and RipK3 are resistant to Salmonella induced 50 
killing. 51 
• Caspase-1 is capable of killing cells through GSDMD, BID mediated intrinsic 52 
apoptosis and direct activation of caspase-3, -7 and -9.  53 
• Caspase-1 and caspase-8 can act as executioners of cell death if all downstream 54 









Apoptosis, pyroptosis and necroptosis contribute to host protection against diverse 63 
pathogens, but their interplay and the underlying molecular mechanisms coordinating 64 
their interactions have not yet been resolved (Green, 2019). To define the relative 65 
importance of these cell death pathways and their inter-connectivity in host defence, we 66 
deleted caspases-1/-11/-12/-8 and RIPK3 in varying combinations to generate mice 67 
lacking pyroptosis, death receptor-induced apoptosis and/or necroptosis, and subjected 68 
them to Salmonella enterica serovar Typhimurium (S. Typhimurium) infection. The loss 69 
of each cell death pathway alone had only minor impact on pathogen control but the 70 
combined absence of pyroptosis, caspase-8 mediated apoptosis and necroptosis led to a 71 
failure to clear the pathogen and consequently severe sickness of Salmonella infected 72 
Casp1/11/12/8/Ripk3–/–mice. Bone marrow derived macrophages (BMDMs) lacking 73 
individual cell death pathways were potently killed upon Salmonella infection, while 74 
Casp1/11/12/8/Ripk3–/– BMDMs were fully resistant and failed to control intracellular 75 
bacterial growth, demonstrating that cells can employ varying cell death processes to 76 
limit intracellular infections. We show that this functional overlap between cell death 77 
pathways was afforded by extensive signaling cross-talk between the initiators and 78 
effectors of pyroptosis (caspase-1/11, GSDMD) and apoptosis (BID, BAX, BAK & 79 
caspases-3/6/7/8/9). Strikingly, Salmonella infection could kill BMDMs even in the 80 
absence of all known executioners of cell death as long as caspase-1 and caspase-8 were 81 
present, indicating that these caspases can act not only as initiators but also as 82 
executioners of cell death. These findings indicate that apoptosis, pyroptosis and to a 83 
lesser extent necroptosis constitute components of a highly intertwined and coordinated 84 
cell death system that provides the host with remarkable flexibility and fail-safe processes 85 
for the control of intracellular infections.   86 
 5 
INTRODUCTION 87 
Metazoans not only depend on the regulated division and multiplication of cells, but also 88 
require their coordinated removal through different types of programmed cell death (PCD), 89 
such as apoptosis, necroptosis and pyroptosis (Green, 2019). Cell demolition during apoptosis 90 
is executed by so-called effector caspases (caspase-3, -6 and -7) that promote cellular 91 
fragmentation into apoptotic bodies and engulfment of dying cells by neighbouring cells 92 
(Salvesen and Dixit, 1997). This facilitates the immunologically ‘silent’ removal of the remains 93 
of dead cells, thereby preventing lytic rupture that mediates release of intracellular content 94 
causing inflammation (Nagata, 2018). Apoptosis can be induced either by death receptors, such 95 
as FAS or TNFR1, that activate caspase-8, or through cellular stress via the intrinsic (also 96 
called BCL-2 regulated or mitochondrial) pathway involving BH3-only protein-initiated and 97 
BAX/BAK-mediated mitochondrial outer membrane permeabilization (MOMP) (Czabotar et 98 
al., 2014). This causes activation of the initiator caspase, caspase-9, and consequent activation 99 
of the effector caspases. Pyroptosis is induced through NLR-dependent activation of caspase-100 
1 or LPS-induced activation of caspase-11 (Lamkanfi and Dixit, 2014; Zhao and Shao, 2016), 101 
while ligation of TNFR1 or Toll-like receptors (TLRs) causes phosphorylation of RIPK1 and 102 
RIPK3 to initiate necroptosis in the absence of caspase-8 activity (Ofengeim and Yuan, 2013; 103 
Vandenabeele et al., 2010). Interestingly, pyroptosis and necroptosis are both executed through 104 
large pores in the cell membrane that cause water influx, cellular swelling and loss of 105 
membrane potential. The cell bursts and exposes its content to the extracellular space, which 106 
can elicit a variety of pro-inflammatory responses priming both the innate as well as the 107 
adaptive immune systems. Although we know many details about the molecular circuits 108 
responsible for triggering these individual pathways of cellular suicide, it is not clear why so 109 
many seemingly parallel pathways have been conserved throughout evolution.  110 
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One important biological function of cellular suicide pertains to the role of programmed cell 111 
death (PCD) in controling intracellular pathogens (Jorgensen et al., 2017; Kayagaki et al., 112 
2015; Shi et al., 2015). The killing of infected cells is thought to remove a replicative niche, 113 
re-expose the pathogen to extracellular immune effector mechanisms and make antigens 114 
available for triggering pathogen-specific adaptive immune responses. Salmonella has been 115 
widely used as a model for studying the role of programmed cell death in host defence (Broz 116 
et al., 2012; Franchi et al., 2009). This intracellular pathogen can cause typhoid fever, a 117 
systemic infection that affects 10-20 million people worldwide and kills >135,000 individuals 118 
per annum (Browne et al., 2020). The disease can be modeled by infecting mice with S. 119 
Typhimurium (Kupz et al., 2014) and spleen and liver are major sites of replication in systemic 120 
Salmonella infections. The primary target of Salmonella spp. are phagocytes, in which the 121 
bacteria survive by repurposing a host cell-derived membrane compartment into a specialized 122 
niche. Phagocytes, such as macrophages, respond to Salmonella infection through 123 
inflammasome formation involving NAIP2/5 and nucleotide-binding oligomerization domain-124 
like receptors (NLR), such as NLRC4 and NLRP3 (Franchi et al., 2009; Miao et al., 2010), that  125 
activate caspase-1 (Zhang et al., 2015). The resulting proximity-induced activation of Caspase-126 
1 causes the proteolytic maturation of the inflammatory cytokines IL-1b and IL-18 and releases 127 
N-terminal fragments of gasdermin D (GSDMD) that form pores in the cell membrane to elicit 128 
pyroptosis. Although these processes appear highly relevant in vitro, with caspase-1 or 129 
GSDMD-deficient phagocytes resisting Salmonella-induced cell death (Franchi et al., 2006; 130 
Mariathasan et al., 2004), in vivo studies suggest that Salmonella can be controlled in the 131 
absence of inflammasome-driven pyroptosis (Broz et al., 2010). This may reflect the capacity 132 
of the host to compensate for the lack of one type of cell death by using another. Such “fail-133 
safe” systems have been hypothesized before and may represent the host’s response to offset a 134 
variety of evasion strategies employed by pathogens to prevent immune recognition (Bedoui 135 
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et al., 2010). Very little is known about the organization, regulation and kinetics of such 136 
functional backup in the use of different programmed cell death pathways during host defence 137 
against pathogens in vivo. Here, we investigated the relative contributions of all initiator and 138 
executioner caspases and the cell death effectors they activate to provide host defence against 139 
systemic Salmonella infections. 140 
 141 
  142 
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RESULTS 143 
Combined Loss of Caspase-1/11/12 and Caspase-8 Prevents Salmonella-Induced Cell 144 
Death and Impairs Bacterial Clearance in vivo 145 
We infected C57BL/6 (wild-type: WT) mice with a growth-attenuated strain of  S. 146 
Typhimurium that mirrors the systemic phase of typhoid fever (Kupz et al., 2014; Kupz et al., 147 
2013). This infection follows a classical pattern where bacterial growth initially outpaces host 148 
defense. By about week 3, bacterial titers reach a peak that is followed by dropping titres and 149 
eventual clearance of the bacteria from the host. This type of infection thus allows detailed in 150 
vivo investigations into the mechanisms that enable control of this globally relevant 151 
intracellular pathogen by innate immune mechanisms over the first 3 weeks of the infection 152 
(Kupz et al., 2012; Kupz et al., 2013) and T cell-mediated immune clearance thereafter 153 
(Benoun et al., 2018). Consistent with earlier reports using WT strains of S. Typhimurium 154 
(Broz et al., 2012), we observed slightly elevated bacterial titres in Casp1/11–/– mice 3 weeks 155 
post-infection compared to WT controls (Figure 1A), but the lack of pyroptosis in these mice 156 
did not affect their capacity to clear the bacteria at 12-weeks post-infection, indicating a 157 
selective defect in bacterial control albeit minor in magnitude. Exploiting this in vivo model of 158 
caspase-1/11-independent bacterial control, we explored the role of other cell death pathways 159 
and their key constituents. We first investigated whether the lack of caspases-1 and -11 was 160 
compensated for by caspase-12, given their substantial amino acid similarity and chromosomal 161 
co-localization. However, at week 3 post-infection Casp1/11/12–/– and Casp1/11–/– mice 162 
presented with comparable minor increases in bacterial titres that were similar to those 163 
observed in WT controls (Figure 1B). This reveals that caspase-12 does not play a critical role 164 
in bacterial clearance in vivo by compensating for the combined absence of caspases-1 and -165 
11.  166 
 167 
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Caspase-8 has been suggested to coordinate an alternative pathway towards pyroptotic cell 168 
death that operates independently of caspases-1/11 (Mascarenhas et al., 2017; Orning et al., 169 
2018), which prompted us to investigate the contribution of caspase-8 driven cell death to 170 
Salmonella control in mice. To prevent the necroptosis-dependent embryonic lethality caused 171 
by loss of caspase-8, we used Casp8/Ripk3–/– mice (Alvarez-Diaz et al., 2016; Kaiser et al., 172 
2011; Oberst et al., 2011). The lack of caspase-8-mediated apoptosis and RIPK3-driven 173 
necroptosis alone did not have any significant impact on Salmonella titres 3 weeks post-174 
infection (Figure 1B), indicating that additional cell death processes were required for bacterial 175 
control. Interestingly, mice lacking necroptosis alone (Mlkl–/– mice) or even mice with 176 
combined deficiency in pyroptosis and necroptosis (Casp1/11/12/Ripk3–/– mice) had no defects 177 
in bacterial control until at least three weeks post-infection (Figure 1B and S1A). These 178 
findings demonstrate that mice with defects in select types of programmed cell death only have 179 









Figure 1. Combined Loss of Caspase-1/11/12 and Caspase-8 Leads to Lack of Bacterial 188 
Clearance upon Salmonella Infection. 189 
(A) Clearance kinetics of WT and Casp1/11–/– mice infected with Salmonella ΔAroA (200 190 
CFU). N=10-22 mice per group per time point. Mean and SEM are shown. **P<0.005, *P<0.05, 191 
nsP>0.05=not significant.  192 
(B) Bacterial loads in spleen and liver 3 week post infection of WT, Casp1/11–/–, Casp1/11/12–193 
/–, Casp1/11/12/Ripk3–/–, Casp8/Ripk3–/– and Casp1/11/12/8/Ripk3–/– mice infected with 194 
Salmonella ΔAroA (200 CFU). N=7-48 mice per group. Mean and SEM are shown. **P<0.005, 195 
*P<0.05, nsP>0.05=not significant.  196 
(C) Bacterial loads in spleen and liver from 1-week to 3-week post-infection of WT and 197 
Casp1/11/12/8/Ripk3-/- mice with Salmonella ΔAroA (200 CFU). N=3-4 mice per genotype and 198 
time point. Mean and SEM are shown. **P<0.005, *P<0.05, nsP>0.05=not significant. 199 
(D) Mouse survival curves and corresponding bacterial loads in the spleen and the liver at time 200 
of sacrifice in WT and Casp1/11/12/8/Ripk3-/- mice infected with Salmonella ΔAroA (200 201 
CFU). N=7-8 mice per group. Mean and SEM are shown. **P<0.005. 202 
(E) Bone marrow chimeras of the indicated genotypes were infected with Salmonella ΔAroA 203 
(200 CFU) and culled for analysis of bacterial loads in spleen and liver 3 weeks post infection. 204 




These findings raised the possibility that in vivo control of Salmonella infection is safeguarded 208 
by extensive functional back-up between several programmed cell death processes. To 209 
investigate this directly, we generated Casp1/11/12/8/Ripk3–/– mice that are deficient for 210 
pyroptosis, extrinsic apoptosis and necroptosis. Strikingly, these mice had drastically elevated 211 
bacterial titres in their liver and spleen at week 2 and 3 post-infection, respectively, compared 212 
to WT animals (Figure 1B,C), and eventually succumbed to the infection between 4 and 5 213 
weeks post-infection (Figure 1D). This shows that host defence against Salmonella necessitates 214 
the activity of at least one of these types of programmed cell death pathways and that none of 215 
the other known cell death pathways (e.g. intrinsic apoptosis or ferroptosis) were sufficient to 216 
ensure control of the infection in their absence. Of note, we observed similar defects in host 217 
defence in bone marrow chimeras in which pyroptosis, caspase-8-mediated apoptosis and 218 
necroptosis were only missing from the immune cell compartment (Figure 1E). Therefore, we 219 
conclude that Salmonella control broke down in Casp1/11/12/8/Ripk3–/– mice because 220 
phagocytes could no longer purge the bacteria from their vacuolar compartments by 221 




Figure S1: Necroptosis Does Not Affect Bacterial Clearance or Provide Back-up for Loss 225 
of Pyroptosis  226 
(A) Bacterial loads in spleen and liver 3-week post infection in WT, and Mlkl–/– mice infected 227 
with Salmonella ΔAroA (200 CFU). N=8 mice per group. Mean and SEM are shown. *P<0.05, 228 
nsP>0.05=not significant. 229 
(B) WT, Casp1/11–/– and Casp1/11/12–/– BMDMs were infected with Salmonella SL1344 230 
(MOI=50) and phosphorylation of MLKL analysed by Western blotting at the indicated 231 








Combined Loss of Caspase-1/11/12 and Caspase-8 Prevents Salmonella Induced Killing 239 
of BMDMs  240 
Previous reports suggest that caspase-8 can induce pyroptotic cell death through cleavage of 241 
GSDMD (Mascarenhas et al., 2017). To explore the nature of the cell death induced by caspase-242 
8 upon infection in cells lacking pyroptotic initiators, we used bone marrow-derived 243 
macrophages (BMDM) deficient for caspases-1/11 or caspases-1/11/12 and infected them with 244 
Salmonella. As previously reported, Casp1/11–/– BMDMs were protected from Salmonella-245 
induced killing at very early time points (Franchi et al., 2006; Mariathasan et al., 2004). 246 
However, 6 h after infection with Salmonella a substantial fraction of Casp1/11–/– and also 247 
Casp1/11/12–/– BMDMs had died (Figure 2A). This reiterates that caspase-12 is not critical for 248 
the response to Salmonella infection. The delayed type of Salmonella-induced cell death in 249 
Casp1/11–/– and Casp1/11/12–/– BMDMs was unlikely to be due to necroptosis, as we could 250 
not detect changes in phosphorylation of MLKL, which are hallmarks of necroptosis (Figure 251 
S1B). Instead, Casp1/11–/– and Casp1/11/12–/– BMDMs displayed classical features of 252 
apoptosis, including cleavage of PARP as well as caspases-3, -7, -8 and -9 (Figure 2B), which 253 
extends a previous report showing that anthrax lethal toxin can induce a NLRP1-dependent 254 
form of cell death with comparable features of apoptosis in cells lacking caspase-1 (Van 255 
Opdenbosch et al., 2017). Lattice light sheet microscopy revealed nuclear condensation and 256 
plasma membrane blebbing. This is consistent with apoptotic death of Salmonella-infected 257 
Casp1/11/12–/– BMDMs and is in striking contrast to the pyroptotic death observed in 258 
Salmonella-infected WT BMDMs (Figure 2C and Suppl. Movies 1-3). Notably, combined loss 259 
of caspase-8 plus RIPK3 did not impair Salmonella-induced cell killing, as in vitro infected 260 
Casp8/Ripk3–/– BMDMs died with kinetics that were indistinguishable from WT cells, with 261 
both undergoing pyroptosis (Figure 2A). This is consistent with the observation that the 262 
combined loss of caspase-8 and RIPK3 did not impair bacterial control in vivo until at least 3 263 
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weeks post-infection (Figure 1B). These findings indicate that although caspase-8 was 264 
dispensable for the early pyroptotic cell death upon Salmonella infection, caspase-8 driven 265 
apoptosis rather than caspase-8 mediated pyroptosis or RIPK3/MLKL-driven necroptosis was 266 
responsible for the delayed type of cell death observed in Casp1/11/12–/– BMDMs. Strikingly, 267 
BMDMs from Casp1/11/12/8/Ripk3–/– mice that are unable to undergo pyroptosis, necroptosis 268 
and caspase-8 driven apoptosis were not only fully resistant to Salmonella-induced killing in 269 
vitro (Figure 2A), but also contained large numbers of bacteria (Figure 2C). This remarkable 270 
resistance to Salmonella-induced killing was not due to a general defect in cell death, as 271 
Casp1/11/12/8/Ripk3–/– BMDMs could still be killed through the intrinsic pathway of apoptosis 272 
by treatment with BH3 mimetic drugs, as shown by LDH release and activation of the apoptosis 273 
effector BAX (Figure S2A,B). Collectively, these findings uncover an intriguing back-up 274 
system that enables the host to flexibly deploy different types of programmed cell death for the 275 










Figure 2. Combined Loss of Caspases-1/11/12 and Caspase-8 Abrogates the Death of 285 
BMDMs upon Salmonella Infection. 286 
(A) LDH release cell death assay of WT, Casp1/11–/–, Casp1/11/12–/–, Casp8/Ripk3–/– and 287 
Casp1/11/12/8/Ripk3–/– primary BMDMs infected with Salmonella SL1344 (MOI=50). Data 288 
pooled from 2 or more experiments. Mean and SEM are shown. **P<0.005; nsP>0.05=not 289 
significant.    290 
(B) WT, Casp1/11–/– and Casp1/11/12–/– BMDMs were infected with Salmonella SL1344 291 
(MOI=50) and cleavage/activation of the indicated cell death regulators were analyzed by 292 
Western blotting at the indicated time points. Probing for ß-actin served as a loading control.  293 
(C) Confocal or lattice light sheet imaging of WT, Casp1/11/12–/– or Casp1/11/12/8/Ripk3–/–- 294 
primary BMDMs infected with Salmonella SPi-2 (GFP) (MOI=50) at the indicated time 295 
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Figure S2. Primary BMDMs from Casp1/11/12/8/Ripk3-/- Mice Are Susceptible to 302 
Intrinsic Apoptosis Induced by BH3 Mimetic Drugs. 303 
(A) Casp1/11/12/8/Ripk3–/– BMDMs were treated with BH3 mimetic drugs individually (2 µM 304 
MCL1i) or in combination (each 2 µM of MCL1i + BCL2i + BCL-XLi) as indicated. Cell 305 
death was measured using an LDH release assay. Data pooled from 2 or more experiments. 306 
Mean and SD are shown. **P<0.005.  307 
(B) Immunoprecipitation and immunoblotting of activated BAX in Casp1/11/12/8/Ripk3–/– 308 
BMDMs infected with Salmonella SL1344 (MOI=50) and/or treated with BH3 mimetic drug 309 
combination (each 2 µM of MCL1i + BCL2i + BCL-XLi). 310 
 311 
 312 
  313 
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Immortalized BMDMs facilitate unravelling of the diverse cell death mechanisms 314 
induced upon Salmonella infection.   315 
To gain a deeper understanding of this complex system of functional backup between different 316 
cell death processes, we used our CRISPR/Cas9 gene knockout platform (Aubrey et al., 2015) 317 
to identify the initiators and effectors that are critical for driving the respective types of cell 318 
death upon Salmonella infection in vitro. We used immortalized BMDMs (iBMDMs) for these 319 
experiments, which exhibited comparable responses to Salmonella infection as primary 320 
BMDMs (Figure 3A,B). While the combined loss of caspases-1/11/12 delayed Salmonella-321 
induced killing of iBMDMs, the combined deletion of caspase-8 and RIPK3 had no impact and 322 
cells died in a manner comparable to WT cells (Figure 3A). Only the combined deletion of 323 
caspases-1/11/12 plus caspase-8/RIPK3 was able to completely block Salmonella infection 324 
induced killing of iBMDMs (Figure 3A). To test whether the genetically manipulated 325 
Casp1/11/12/8/Ripk3KO iBMDMs were completely unable to undergo cell death as was the 326 
case for primary BMDMs (Figure S2A,B), we treated them with combinations of BH3 327 
mimetics or etoposide (Figure S3A,B). These treatments resulted in efficient killing of the 328 
Casp1/11/12/8/Ripk3KO iBMDMs, accompanied by activation of the apoptosis effector BAX 329 
(Figure S3A,B). 330 
Interestingly we noted that in the absence of caspases-1/11/12, infection of iBMDMs with 331 
Salmonella led to a strong induction of caspase-8 and caused the appearance of classical 332 
markers of apoptosis, such as cleaved BID, caspases-3, -7 and -9 (Figure 3B). Casp1/11/12KO 333 
cells infected with Salmonella in the absence or presence of the highly selective RIPK1 334 
inhibitor, Nec1s (Figure 3C, D) still underwent cell death and activated caspase-8, BID and 335 
caspase-3. As Nec1s blocked necroptosis induced by a combination of TNF-336 
a+Birinipant+Emricasan in control experiments (Figure S4A), these findings indicate that the 337 
activation of caspase-8 under these conditions was unlikely to be caused by the ripoptosome 338 
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(Tenev et al., 2011).   Collectively, these results validate iBMDMs as useful tools to unravel 339 
the molecular requirements of the diverse cell death pathways induced upon Salmonella 340 
infection.  341 
 342 
Figure 3. Caspase-8-Mediated Apoptosis Is the Default Backup Mechanism when 343 
Caspase1/11-Mediated Pyroptosis Is Disabled in Salmonella infected iBMDMs.  344 
(A) LDH release cell death assay of WT, Casp1/11/12KO, Casp8/Ripk3KO and 345 
Casp1/11/12/8/Ripk3KO iBMDMs infected with Salmonella SL1344 (MOI=50). Data pooled 346 
from 2 or more experiments. Mean and SEM are shown. **P<0.005; nsP>0.05=not significant.    347 
(B) Western blot analysis of the indicated proteins in WT, Casp1/11/12KO and 348 
Casp1/11/12/8/R3KO iBMDMs infected with Salmonella SL1344 (MOI=50). Probing for ß-349 
actin served as a loading control. 350 
(C) LDH release cell death assay of Salmonella SL1344 (MOI=50) infected WT and 351 
Casp1/11/12KO iBMDMs that had been left untreated or treated with the RIPK1 inhibitor, 352 
Nec1s (30 µM). Data pooled from 2 or more experiments. Mean and SEM are shown. 353 
**P<0.005; nsP>0.05=not significant.    354 
(D) Western blot analysis of Salmonella SL1344 (MOI=50) infected WT and Casp1/11/12KO 355 
iBMDMs that had been left untreated or treated with the RIPK1 inhibitor, Nec1s (30 µM). 356 
Probing for ß-actin served as a loading control. 357 





Figure S3. Casp1/11/12/8/Ripk3KO iBMDMs Are Susceptible to Intrinsic Apoptosis 362 
Induced by BH3 Mimetic Drugs 363 
(A) LDH release cell death assay of WT and Casp1/11/12/8/Ripk3KO iBMDMs after 24 h 364 
treatment with combination of BH3 mimetic drugs (each 2 µM of MCL1i + BCL-2i + BCL-365 
XLi), Etoposide (50 µM) or infection with Salmonella SL1344 (MOI=50). Mean and SEM are 366 
shown. **P<0.005; nsP>0.05=not significant.  367 
(B) Immunoprecipitation and immunoblotting of activated BAX in WT and 368 
Casp1/11/12/8/Ripk3KO iBMDMs infected with Salmonella SL1344 (MOI=50) or treated with 369 
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Caspase-11 can partially compensate for the loss of caspase-1 and caspase-8 by triggering 378 
GSDMD-dependent death of Salmonella infected cells 379 
To identify which of the initiator caspases-1, -11, -12 or -8 are necessary for induction of cell 380 
death in Salmonella-infected cells, we treated WT, Casp1/11/12KO and Casp8/Ripk3KO 381 
iBMDMs with different caspase inhibitors and examined the cell death response (Figure 4A 382 
and Figure S4B). Surprisingly, the pan-caspase inhibitor Emricasan could stalled the early cell 383 
death response as observed in Casp1/11/12–/– BMDMs, but did not prevent the subsequent cell 384 
death induced upon Salmonella infection in WT cells (Figure 4A). We hypothesised that this 385 
was due to necroptosis following blockade of caspase-8, which we confirmed by the induction 386 
of cell death in WT but not MLKL-deficient cells treated with Emricasan (Figure S4B). 387 
Accordingly, we could completely block the killing of Salmonella-infected MLKLKO iBMDMs 388 
by treatment with Emricasan (Figure 4A), clearly demonstrating that caspase activity is 389 
required for Salmonella-induced cell killing. As expected, caspase-1 inhibition by VX765 390 
delayed but did not affect the overall survival of Salmonella infected WT, MLKLKO and 391 
Casp1/11/12KO cells (Figure S4A and 4A). These findings not only validate the above 392 
observations through pharmacological approaches, but also indicate that the phenomena 393 
described so far are not the consequence of longer-term adaptations caused by the loss of the 394 
genes of interest.  395 
Notably, inhibition of caspase-1 activity using VX765 or genetic deletion of caspase-1 in 396 
Casp8/Ripk3KO iBMDMs did not fully recapitulate the striking survival of Salmonella-infected 397 
Casp1/11/12/8/Ripk3KO iBMDMs although it delayed their killing (Figure 4A & B). We 398 
therefore surmised that caspase-11 provided a back-up mechanism for cell killing when 399 
caspase-1 and caspase-8 were absent or inhibited  (Man et al., 2017; Ng and Monack, 2013). 400 
To investigate this, we generated Casp1/11/8/Ripk3KO iBMDMs and compared their death 401 
kinetics to those of Casp1/11/12/8/Ripk3KO cells. Casp1/8/Ripk3KO iBMDMs responded to the 402 
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infection by upregulation of caspase-11 and cell killing, although it was noteworthy that cell 403 
death was less effective with ~60-70% of the cells surviving the bacterial assault (Figure 4B, 404 
D). Casp1/11/8/Ripk3KO phenocopied Casp1/11/12/8/Ripk3KO cells in that they were fully 405 
resistant to Salmonella-induced death (Figure 4B), once again underlining the redundancy of 406 
caspase-12 for cell death during infection with this intracellular pathogen (Figure 4B). The 407 
pan-caspase inhibitor Emricasan completely blocked the cell death in Salmonella-infected 408 
Casp1/8/Ripk3KO iBMDMs and we could no longer detect activated forms of GSDMD, the 409 
critical effector of pyroptosis (Figure 4 C, D). Notably, infection of Casp1/8/Ripk3KO iBMDMs 410 
with Salmonella did not result in the occurrence of apoptotic markers, such as cleaved BID or 411 
PARP (Figure 4D), and the additional deletion of GSDMD rendered Casp1/8/Ripk3KO 412 
iBMDMs fully resistant to Salmonella-induced killing (Figure 4C). Thus, although caspase-11 413 
can kill some Salmonella infected cells in the absence of caspase-1 and caspase-8, the 414 
protracted kinetics and exclusive dependence on GSDMD suggest a comparatively minor role 415 











Figure 4: Caspase-11 Can Compensate for the Loss of Caspase-1 and Caspase-8 to Ensure 426 
GsdmD-Mediated Killing of Salmonella Infected Cells. 427 
(A) LDH release cell death assay of Salmonella SL1344 (MOI=50) infected WT, MLKLKO, 428 
Casp1/11/12KO, Casp8/Ripk3KO and Casp1/11/12/8/Ripk3KO iBMDMs that had been left 429 
untreated or treated with VX-765 or Emricasan. Data pooled from 2 or more experiments. 430 
Mean and SEM are shown. **P<0.005; nsP>0.05=not significant.    431 
(B) LDH release cell death assay of WT, Casp1/8/Ripk3KO, Casp1/11/8/Ripk3KO and 432 
Casp1/11/12/8/Ripk3KO iBMDMs that had been infected with Salmonella SL1344 (MOI=50). 433 
Data pooled from 2 or more experiments. Mean and SEM are shown. **P<0.005; nsP>0.05=not 434 
significant.    435 
(C) LDH release cell death assay of WT, Casp1/8/Ripk3KO, Casp1/8/Ripk3/GsdmdKO and 436 
Casp1/11/12/8/Ripk3KO iBMDMs or Casp1/8/Ripk3KO that had been left untreated or treated 437 
with Emricasan that had been infected with Salmonella SL1344 (MOI=50). Data pooled from 438 
2 or more experiments. Mean and SEM are shown. **P<0.005; nsP>0.05=not significant.    439 
(D) Western blot analysis of caspase-11, GSDMD, BID and PARP in Casp1/8/R3KO iBMDMs 440 
that had been left untreated or treated with Emricasan that had been infected with Salmonella 441 
SL1344 (MOI=50). WT iBMDMs that had been left untreated or treated with LPS for 4h were 442 
used as control for caspase-11 induction. Probing for ß-actin served as a loading control. 443 
 23 
 444 
Figure S4: Impact of RIPK1 Inhibition by Nec1s and Effect of Caspase-1 Inhibition or 445 
Inhibition of All Caspases on the Survival of iBMDM.  446 
(A) WT iBMDMs were treated with TNF-a (100 ng/mL) + Birinapant (1 µM) + Emricasan 447 
(20 µM) with or without the RIPK1 inhibitor Nec1s (30 µM) and cell death was measured by 448 
LDH release. Data pooled from 2 or more experiments. Mean and SEM are shown. **P<0.005; 449 
nsP>0.05=not significant.    450 
(B) LDH release cell death assay of WT, MLKLKO, Casp1/11/12KO, Casp1/11/12/MLKLKO, 451 
Casp8/Ripk3KO and Casp1/11/12/8/Ripk3KO iBMDMs that had been treated with the caspase-1 452 
specific inhibitor, VX-765 (20 µM), or the broad-spectrum caspase inhibitor, Emricasan (20 453 
µM). Data pooled from 2 or more experiments. Mean and SEM are shown. **P<0.005; 454 





Caspase-1 orchestrates a wide range of diverse cell death inducing processes with 459 
remarkable plasticity 460 
Although our data show an important role for caspase-8 in compensating for the lack of 461 
pyroptosis (in mice lacking caspases-1/11/12), it was also evident that host defense was intact 462 
in mice lacking both caspase-8 and RIPK3 (Figure 1B).  This suggests that there may not only 463 
be redundancy amongst the different cell death pathways, but that individual components of 464 
these processes could possibly be employed in more than one pathway. With this in mind, we 465 
reasoned that the lack of caspase-8-mediated apoptosis might be compensated for by caspase-466 
1. To investigate this, we deleted GSDMD to prevent caspase-1 and caspase-11 from triggering 467 
pyroptosis and also eliminated caspase-8 and RIPK3 from iBMDMs. Intriguingly, cells lacking 468 
these essential components of apoptosis and necroptosis as well as being unable to execute 469 
pyroptosis still died upon Salmonella infection with kinetics that were indistinguishable from 470 
GsdmdKO iBMDMs (Figure 5A). We noted that Salmonella-infected Gsdmd/Casp8/Ripk3KO 471 
iBMDMs not only had active caspase-1, as predicted, but also contained cleaved BID (tBID) 472 
and cleaved caspases-3, -7 and -9 (Figure 5B). This indicates that caspase-1 may trigger 473 
caspase-8-independent apoptosis via BID-driven, BAX/BAK-mediated MOMP and the 474 
resulting activation of caspase-9, thereby stimulating the effector caspases-3 and -7. This is 475 
consistent with recent reports (Heilig et al., 2020; Tsuchiya et al., 2019) and suggests that 476 
caspase-1 can induce apoptosis by bypassing caspase-8 through the mitochondrial 477 
amplification loop. Intriguingly, preventing MOMP through the combined deletion of BAX 478 
and BAK in Gsdmd/Casp8/Ripk3KO iBMDMs did not have the expected effect of blocking 479 
Salmonella induced cell killing; instead, Gsdmd/Casp8/Ripk3/Bax/BakKO iBMDMs still died 480 
upon Salmonella infection containing active caspases-3 and -7 (Figure 5A,B). This indicates 481 
that the absence of BAX/BAK could be compensated for by rewiring the cell in a manner that 482 
allows for caspase-1 to trigger the executioner caspases (caspases-3 and -7) independently of 483 
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MOMP. Surprisingly, ablating this alternative cell death circuit by deleting caspases-3 and -7 484 
was yet again not sufficient to prevent cell death, as Gsdmd/Casp8/Ripk3/Casp3/7KO iBMDMs 485 
still died upon Salmonella infection, although this occurred with slower kinetics compared to 486 
Gsdmd/Casp8/Ripk3/Bax/BakKO iBMDMs (Figure 5C). The fact that 487 
Gsdmd/Casp8/Ripk3/Casp3/7KO iBMDMs still contained cleaved BID (tBID) and cleaved 488 
caspases-1 and -9 suggested that tBID and caspase-9 activated by caspase-1 could overcome 489 
the lack of the executioner caspases to ensure killing of infected cells (Figure 5D). Intriguingly, 490 
additional deletion of BID from Gsdmd/Casp8/Ripk3/Casp3/6/7KO iBMDMs did not render the 491 
cells fully resistant to Salmonella-induced death. This raised the exciting prospect that caspase-492 
1 can directly activate caspase-9, which then acted as an effector caspase rather than an initiator 493 
caspase (Figure 5E). Of note, the deletion of caspase-9 from 494 
Gsdmd/Casp8/Ripk3/Bid/Mlkl/Casp3/7KO iBMDMs finally reproduced the profound resistance 495 
to Salmonella-induced cell killing observed in Casp1/11/12/8/Ripk3KO iBMDMs (Figure 5F). 496 
These findings reveal a remarkable degree of plasticity with which caspase-1 can orchestrate 497 
the use of diverse cell death-inducing processes to kill Salmonella infected iBMDMs. Caspase-498 
1 can bypass caspase-8 by initiating apoptosis through mitochondrial amplification and can 499 
even circumvent the need for MOMP by activating caspases-3, -7 or -9 directly (see schematic 500 
in Figure 5G). This shows that many core components widely believed to be essential for 501 
apoptosis can be bypassed and that the resulting re-routing of the cell death machinery provides 502 






Figure 5. Caspase-1 Can Activate Caspases-3, -7 and -9 Independently of Caspase-8 and 508 
BID.   509 
(A) LDH release cell death assay of WT, Casp1/11/12/8/Ripk3KO, GsdmDKO, 510 
GsdmD/Casp8/Ripk3KO and GsdmD/Casp8/Ripk3/Bax/BakKO iBMDMs that had been infected 511 
with Salmonella SL1344 (MOI=50). Data pooled from 2 or more experiments. Mean and SEM 512 
are shown. **P<0.005; nsP>0.05=not significant.    513 
(B) GsdmD/Casp8/Ripk3KO and GsdmD/Casp8/Ripk3/Bax/BakKO iBMDMs were infected with 514 
Salmonella SL1344 (MOI=50) and cleavage/activation of the indicated cell death proteins was 515 
analyzed by Western blotting at the indicated time points. Probing for ß-actin served as a 516 
loading control.  517 
(C) LDH release cell death assay of WT, Casp1/11/12/8/Ripk3KO and 518 
GsdmD/Casp8/Ripk3/Mlkl/Casp3/7KO iBMDMs that had been infected with Salmonella 519 
SL1344 (MOI=50). Data pooled from 2 or more experiments. Mean and SEM are shown. 520 
**P<0.005; nsP>0.05=not significant.    521 
(D) GsdmD/Casp8/Ripk3/Mlkl/Casp3/7KO iBMDMs were infected with Samonella SL1344 522 
(MOI=50) and expression and cleavage/activation of the indicated cell death proteins was 523 
analyzed by Western blotting at the indicated time points. Probing for ß-actin served as a 524 
loading control. 525 
(E) LDH release cell death assay of WT, Casp1/11/12/8/Ripk3KO and 526 
GsdmD/Casp8/Ripk3/Bid/Casp3/7KO iBMDMs that had been infected with Salmonella SL1344 527 
(MOI=50). Data pooled from 2 or more experiments. Mean and SEM are shown. nsP>0.05=not 528 
significant. 529 
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(F) LDH release cell death assay of WT, Casp1/11/12/8/Ripk3KO and 530 
GsdmD/Casp8/Ripk3/Mlkl/Bid/Casp3/7/9KO iBMDMs that had been infected with Salmonella 531 
SL1344 (MOI=50). Data pooled from 2 or more experiments. Mean and SEM are shown. 532 
nsP>0.05=not significant. 533 
(G) Schematic overview of cell death induction by caspase-1 in the absence of pyroptosis and 534 




Caspase-1 has a central role as both a cell death inducer and executioner 539 
Our findings provided intriguing insights into the role of caspase-1 and its capacity to 540 
compensate for the lack of caspase-8. However, it is important to note that Casp1/11–/– and 541 
Casp1/11/12–/– mice nonetheless effectively controlled Salmonella infection (Figure 1B). This  542 
highlights yet another form of compensation whereby caspase-1 can also be functionally 543 
replaced. This likely involved caspase-8, as suggested by the observations that 544 
Casp1/11/12/8/Ripk3–/– mice were unable to clear bacteria and that BMDMs derived from these 545 
animals failed to undergo cell death upon infection (Figures 1B,C). We therefore tested the 546 
hypothesis that deleting the death effectors regulated by caspases-1 and -8, i.e. 547 
GSDMD/BID/MLKL/caspase-3/6/7, and possibly also caspase-9, would recapitulate the 548 
profound resistance to Salmonella-induced killing observed in Casp1/11/12/8/Ripk3KO 549 
iBMDMs. However, upon infection with Salmonella both Gsdmd/Bid/Mlkl/Casp3/7/9KO and 550 
Gsdmd/Bid/Mlkl/Casp3/6/7/9KO iBMDMs underwent substantial cell death, although this was 551 
delayed compared to WT iBMDMs (Figure 6A). To identify the most potent upstream 552 
regulator(s) of this unexpected cell killing caused by Salmonella, we performed a genome-553 
wide CRISPR/Cas9 knockout screen (Figure S5A). We transduced Cas9 expressing 554 
Gsdmd/Bid/Mlkl/Casp3/7/9KO iBMDMs with a whole genome sgRNA library (Koike-Yusa et 555 
al., 2014) and stringently enriched for sgRNAs that promoted cell survival after Salmonella 556 
infection by repeating the infection/selection procedure three times. Amplicon sequencing of 557 
the sgRNAs enriched in the surviving cells identified caspase-1 and its activator NLRC4 558 
(Figures 6B and S5B).  559 
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 560 
Figure S5. CRISPR/Cas9 Screen Identifies Caspase-1 and NRLC4 as the Central Drivers 561 
of Cell Death in the Absence of all known Downstream Effectors of Cell Killing.  562 
(A) Schematic overview of CRISPR/Cas9 whole genome screen: 563 
Gsdmd/Bid/Mlkl/Casp3/7/9KO iBMDMs were transduced with a whole genome sgRNA library 564 
(Koike-Yusa et al., 2014) and infected in replicates for three consecutive rounds with 565 
Salmonella SL1344 (MOI=50). Surviving cells were expanded and subjected to NGS analysis.  566 
(B) A heatmap of the sgRNAs significantly enriched during the CRISPR/Cas9 screen as shown 567 
per individual replicate, ranked according to false discovery rate. Green arrowheads indicate 568 
sgRNAs for caspase-1 and NLRC4.  569 
  570 
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This raised the possibility that the initiator caspase-1 can kill Salmonella-infected iBMDMs 571 
directly (i.e. acting not only as an initiator but also as an effector caspase), which would also 572 
explain why cells still died in the absence of pore formation (GSDMD) and all other effectors 573 
that are known to function downstream of caspase-1. Consistent with such a role for caspase-574 
1, Western blot analysis revealed processing of both caspase-1 and caspase-8 in Salmonella-575 
infected Gsdmd/Bid/Mlkl/Casp3/7/9KO iBMDMs (Figure 6C). Deletion of caspase-1 in 576 
Gsdmd/Bid/Mlkl/Casp3/7/9KO iBMDMs rendered these cells fully resistant to Salmonella-577 
induced killing despite the presence of caspase-8, which was comparable to 578 
Casp1/11/12/8/Ripk3KO cells (Figure 6D). Together with our demonstration that 579 
Gsdmd/Bid/Mlkl/Casp3/7/9KO iBMDMs in which caspase-8 was deleted (Figure 5E) were also 580 
fully resistant to Salmonella-induced death, these findings indicate that cell death under these 581 





Figure 6. CRISPR Screen Reveals a Central Role for Caspase-1 in Mediating Salmonella 586 
Infection Induced Cell Death Independent of All Known Downstream Effectors of Cell 587 
Killing. 588 
(A) LDH release cell death assay of WT, Casp1/11/12/8/Ripk3KO, 589 
GsdmD/Bid/Mlkl/Casp3/7/9KO and GsdmD/Bid/Mlkl/Casp3/6/7/9KO iBMDMs that had been 590 
infected with Salmonella SL1344 (MOI=50). Data pooled from 2 or more experiments. Mean 591 
and SEM are shown. *P<0.05; nsP>0.05=not significant.    592 
(B) GsdmD/Bid/Mlkl/Casp3/7/9KO whole genome CRISPR/Cas9 screen mean-difference (MD) 593 
plot showing log-fold change vs Average log counts per million (CPM) after 3 rounds of 594 
infection with Salmonella SL1344 (MOI=50) (see Suppl Fig. 5A). 595 
(C) GsdmD/Bid/Mlkl/Casp3/7/9KO iBMDMs were infected with Salmonella SL1344 596 
(MOI=50) and cleavage/activation of caspase-1 and caspase-8 was analyzed by Western 597 
blotting at the indicated time points. Probing for b-actin served as a loading control. 598 
(D) LDH release cell death assay of WT, Casp1/11/12/8/Ripk3KO and two independent clones 599 
(#1; #2) of GsdmD/Bid/Mlkl/Casp3/7/9/1KO iBMDMs that had been infected with Salmonella 600 
SL1344 (MOI=50). Data pooled from 2 or more experiments. Mean and SEM are shown. 601 
nsP>0.05=not significant.    602 
 603 
 604 







































































































Caspase-1 acts upstream of and requires caspase-8 to induce cell death in the absence of 606 
all known downstream cell death effectors 607 
Interestingly, we found that the caspase-8 cleavage we had observed in 608 
Gsdmd/Bid/Mlkl/Casp3/6/7/9KO iBMDMs was strongly reduced in Salmonella-infected 609 
Gsdmd/Bid/Mlkl/Casp1/3/7/9KO iBMDMs (Figure 7A), indicating that caspase-1 was required 610 
for full activation of caspase-8. This identifies caspase-1 as the most potent upstream initiator 611 
of Salmonella-induced cell killing and explains why we only enriched for sgRNAs targeting 612 
caspase-1 and its activator NLRC4 in the CRISPR screen. Supporting this idea, we found that 613 
both the caspase inhibitor Emricasan and the highly specific caspase-1 inhibitor VX-765 614 
completely blocked Salmonella-induced killing of Gsdmd/Bid/Mlkl/Casp3/7/9KO iBMDMs 615 
(Figure 7B). Furthermore, similar to the genetic deletion of Caspase-1, VX-765 almost 616 
completely blocked caspase-8 processing in Salmonella-infected 617 
Gsdmd/Bid/Mlkl/Casp3/6/7/9KO cells (Figure 7C). Of note, this type of cell death that was 618 
ensured as long as both caspase-1 and caspase-8 were present looked morphologically like 619 
apoptosis as demonstrated by brightfield microscopy of Salmonella-infected 620 
Gsdmd/Bid/Mlkl/Casp3/7/9KO iBMDMs (Figure S6). These results show that Salmonella-621 
infected macrophages can undergo programmed cell death in the absence of all known effector 622 
mechanisms of pyroptosis, apoptosis or necroptosis as long as caspase-1 and caspase-8 can be 623 




Figure 7. Caspase-1 Acts Upstream of and Requires Caspase-8 to Induce Cell Death in 627 
the Absence of All Known Downstream Effectors of Pyroptosis and Apoptosis.  628 
(A) GsdmD/Bid/Mlkl/Casp3/7/9/Casp1KO, GsdmD/Bid/Mlkl/Casp3/7/9/Casp8/Ripk3KO and 629 
GsdmD/Bid/Mlkl/Casp3/7/9/Casp6KO iBMDMs were infected with Samonella SL1344 630 
(MOI=50) and cleavage/activation of caspase-1 and caspase-8 was analyzed by Western 631 
blotting at the indicated time points. Probing for HSP70 served as loading control. 632 
(B) LDH release death assay of Salmonella SL1344 (MOI=50) infected 633 
Casp1/11/12/8/Ripk3KO and GsdmD/Bid/Mlkl/Casp3/7/9KO that had been left untreated or 634 
treated with VX-765 or Emricasan. Data pooled from 2 experiments. Mean and SEM are shown. 635 
**P<0.005; nsP>0.05=not significant.    636 
(C) Western blot analysis of caspase-1 and caspase-8 activation at the indicated time points in 637 
Salmonella SL1344 (MOI=50) infected GsdmD/Bid/Mlkl/Casp3/7/9KO iBMDMs that had been 638 
left untreated or treated with VX-765. Probing for HSP70 served as a loading control. 639 
(D) Schematic of cell death pathway hierarchy in the absence of all known downstream 640 




Figure S6. Macrophages Lacking All Downstream Effectors of Caspase-1 and Caspase-8 644 
Undergo Delayed Apoptotic Cell Death upon Salmonella Infection. 645 
WT, Casp1/11/12KO and Gsdmd/Bid/Mlkl/Casp3/7/9KO iBMDM cells were left untreated or 646 
infected with Salmonella SL1344 (MOI=50) and analyzed using brightfield microscopy. Scale 647 











Our findings uncover a highly flexible system of cell death inducing pathways through which 658 
phagocytes can purge bacteria from intracellular niches and thereby enable the host to control 659 
intracellular bacteria. While we have observed and functionally validated the triggering of the 660 
known pathways leading to pyroptosis, necroptosis and apoptosis, our work reveals a 661 
remarkable level of plasticity that allows bacterially infected cells to rewire known cell death 662 
signaling cascades in surprisingly flexible, thus far unknown ways. We identified caspase-1 663 
and caspase-8 as central pillars of this system and demonstrated that multiple previously 664 
unknown versions of rewired cell death circuits can efficiently evict bacteria from intracellular, 665 
most likely vacuolar niches as long as one of these central hubs is present.  666 
 667 
Our results show that caspase-1, but not caspase-11, can kill Salmonella infected cells in the 668 
absence of all known effectors of cell killing (i.e. caspases-3,6,7, BID, GSDMD) and that this 669 
was mediated via caspase-8. We also observed enhanced cleavage of caspase-8 in Salmonella 670 
infected iBMDMs that lacked caspase-1, which suggests that the levels of caspase-8 activation 671 
may be subject to regulation by the activity of caspase-1. Our data excluded non-redundant 672 
roles for ripoptosomes in mediating interactions between these two central regulators of 673 
programed cell death and it is likely that ASC provided the molecular link between caspase-1 674 
and caspase-8 as previously shown in different scenarios (Antonopoulos et al., 2015; Lee et al., 675 
2018; Mascarenhas et al., 2017; Pierini et al., 2012; Rauch et al., 2017; Sagulenko et al., 2013; 676 
Schneider et al., 2017; Van Opdenbosch et al., 2017). Whether the strong activation of caspase-677 
8 in the absence of caspase-1 is indicative of some bona fide, yet to be uncovered inhibitory 678 
effects reminiscent of the role of caspase-8 in preventing necroptosis (Oberst et al., 2011) or 679 
rather reflects differential kinetics, whereby the more rapid induction of pyroptosis simply kills 680 
cells before caspase-8 is fully activated and thus only becomes appreciable in the absence of 681 
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caspase-1, requires further examination. Remarkably this requirement for caspase-8 682 
downstream of caspase-1 was not absolute, as Salmonella-infected iBMDMs lacking caspase-683 
8 and RIPK3 still died as long as caspase-9 was present even when the effector caspases-3 and 684 
-7 where missing. It is tempting to speculate that caspase-9 was directly activated by caspase-685 
1 through a MOMP independent mechanism under these conditions, as cell death still depended 686 
on caspase-1. Regardless of the precise molecular mechanisms underpinning the observed 687 
phenomena, our findings highlight a role for caspase-1 as a master regulator in the orchestration 688 
of multiple cell death pathways during infection with intracellular pathogens, which bears 689 
resemblance to recent data proposing a similar role for caspase-8 during embryonic 690 
development (Fritsch et al., 2019; Newton et al., 2019). Importantly, however, host defence 691 
can also be maintained in the absence of caspase-1, but this depends on the intactness of the 692 
downstream effector machinery that under such conditions is coordinated by caspase-8 instead. 693 
 694 
It was also interesting that the various alternative circuits of cell death uncovered here all 695 
resulted in morphological features characteristic of apoptosis. Thus, rather than one type of 696 
lytic cell death, such as pyroptosis, being compensated for by another form of programmed 697 
cellular lysis (i.e. necroptosis), our study and recent work by others (Mascarenhas et al., 2017; 698 
Van Opdenbosch et al., 2017) indicate that the absence of lytic cell death appeared to be backed 699 
up by apoptosis. This is particularly interesting because lytic and non-lytic types of cell death 700 
are believed to differ substantially in their consequences for the host, with the former 701 
promoting inflammation while the latter often being referred to as immunologically silent. Yet 702 
we found here that in vivo control of Salmonella proceeded largely undeterred irrespective of 703 
these functional differences. More work is required to dissect how the qualitatively different 704 
forms of cell death impact on the ultimate clearance of the bacteria through adaptive immune 705 
responses mediated by CD4+ T cells and CD8+ T cells (Kupz et al., 2014; Kupz et al., 2012).  706 
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 707 
A potential ‘backup’ role for caspase-11 in synergizing, enhancing or even compensating for 708 
caspase-1 in host defense against intracellular pathogens has been the focus of previous studies 709 
(Broz et al., 2012; Ng and Monack, 2013). Our data indicate that caspase-11 can indeed play a 710 
minor role in pathogen clearance, not only synergistically with but also independently of 711 
caspase-1 and caspase-8. However, caspase-11 could only induce death in some cells upon 712 
Salmonella infection and this was strictly dependent on the activation of GSDMD, 713 
demonstrating its limiting backup ability, compared to caspase-1 which can also kill through 714 
caspases-3, -7, -9 and -8 or act as a cell death executioner itself.  715 
 716 
Taken together, our work demonstrates a remarkable level of flexibility and plasticity with 717 
which macrophages can commit suicide to purge Salmonella from intracellular hideouts. As 718 
long as caspase-1 or caspase-8 are active, molecular components previously thought to be 719 
unique to particular types of programmed cell death can be flexibly rewired and thus ensure 720 
the death of Salmonella-infected macrophages even when all currently known executioner 721 
molecules are absent. Such a complex system has likely arisen as a consequence of host-722 
pathogen co-evolution and the never-ending struggle between pathogens seeking to evade cell 723 
death and the host offsetting these attempts through the rewiring of cell death circuits. While 724 
we focussed in the present study on a prototypical intracellular pathogen with global relevance, 725 
it is interesting to note that extracellular bacterial pathogens, such as Staphylococcus aureus, 726 
also express and inject effector molecules capable of manipulating apoptosis into host cells 727 
through their type VII secretion systems. This suggests that programed cell death may therefore 728 
also play an important role in the host response against extracellular bacteria and its is tempting 729 
to speculate that the extracellular lifestyle of some bacteria could be considered as yet another 730 
evasion strategy of cell death. 731 
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STAR METHODS 761 
KEY RESOURCES TABLE 762 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
rat anti-caspase-11 (4E11) WEHI N/A 
rat anti-caspase-1 (1H11) WEHI N/A 
rat anti-BID (2D1-3) WEHI N/A 
mouse anti-PARP (C2-10) Santa Cruz Cat# sc-53643; RRID: 
AB_785086 
rabbit anti-GSDMD Abcam Cat# EPR19828; RRID: 
AB_2783550 
rabbit anti-Bak  Sigma Aldrich Cat# B-5897; RRID: 
AB_258581 
rat anti-Bax (5B7) WEHI N/A 
Rabbit polyclonal anti-BAX NT Merck Millipore Cat#ABC11; RRID: 
AB_310143 
anti-BAX antibody 6A7 (aa113-19) BD Biosciences Cat# 556467; RRID: 
AB_396430 
rabbit anti-caspase-9 (10-1-87) WEHI N/A 
rabbit anti-caspase-7 (D2Q3L) CST Cat# 12827S; RRID: 
AB_2687912 
rabbit anti-cleaved caspase-3 (Asp175) CST Cat# 9661S; RRID: B_2341188 
rabbit anti-RIPK3 ProSci Cat# 2283; RRID: AB_203256 
rabbit anti-cleaved caspase-8 (D5B2) CST Cat# 8592S; RRID: 
AB_10891784 
rat anti-caspase-8 (3B10) WEHI N/A 
rabbit anti-phospho MLKL (S345) Abcam Cat# ab196436; RRID: RRID: 
AB_2687465 
rat anti-MLKL (3H1) Merck Cat# MABC604; RRID: RRID: 
AB_2820284 
anti-β-actin-HRP (13E5) CST Cat# 5125S; RRID: RRID: 
AB_1903890 
mouse anti-HSP70 (BRM-22) Sigma Aldrich Cat# MA1-91159; RRID: 
RRID: AB_1957733 
Goat anti-rabbit Ig (H/L): HRP 
conjugate 
Southern Biotech Cat# 4010-05; RRID: 
AB_2632593 
Goat anti-rat Ig (H/L): HRP conjugate Southern Biotech Cat# 3010-05; RRID: 
AB_619911 
Goat anti-mouse Ig (H/L): HRP 
conjugate 
Southern Biotech Cat# 1010-05; RRID: 
AB_609673 
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Goat anti-rabbit Ig (Fc): HRP conjugate Southern Biotech Cat# 3030-05; RRID: 
AB_2716837 
Bacterial and Virus Strains  
Stbl3 chemically competent E. coli Invitrogen Cat# C737303 
Chemicals, Peptides, and Recombinant Proteins 
Gentamycin Sigma Aldrich Cat# G-1397 
ABT-199 (Venetoclax) (BCL-2i) ActiveBiochem Cat# A-1231 
S63845 (MCL-1i) ActiveBiochem Cat# A-6044 
A1331852 (BCL-XLi) ActiveBiochem Cat# A-6046 
Etoposide Sigma Aldrich Cat# E-1383 
RIP1 inhibitor II, 7-Cl-O-Nec (10mg) 
(Nec1s) 
Merck Cat# 5.04297.0001 




Emricasan MedKoo Cat# 510230 
VX-765 InvivoGen Cat# inh-vx765i-1 
PhosSTOP phosphatase inhibitor Roche Cat# 04906837001 
EDTA-free Protease inhibitor cocktail Roche Cat# 11836170001 
Proteinase K Roche Cat# 3115879 
dox hyclate Sigma-Aldrich  Cat# D-9891 
Luminata Forte Western HRP substrate  Merck Millipore Cat# WBLUF0500 
Lipopolysaccharide from E.coli Sigma-Aldrich Cat# L-2880 
Critical Commercial Assays 
Promega CyTox LDH assay Promega Cat# G1780 
Experimental Models: Cell Lines 
Primary murine BMDMs this manuscript N/A 
murine WT iBMDMs De Nardo et al 
2018 
N/A 
murine Casp1/11/12KO iBMDMs this manuscript N/A 
murine Casp1/11/12/8/RipK3KO 
iBMDMs 
this manuscript N/A 
murine Casp8/RipK3KO iBMDMs this manuscript N/A 
murine MLKLKO iBMDMs this manuscript N/A 
murine Casp1/8/RipK3KO iBMDMs this manuscript N/A 
murine Casp1/11/8/RipK3KO iBMDMs this manuscript N/A 
murine Casp1/8/RipK3/GsdmdKO 
iBMDMs 
this manuscript N/A 
murine GsdmdKO iBMDMs this manuscript N/A 
murine Gsdmd/Casp8/Ripk3KO iBMDMs this manuscript N/A 
murine Gsdmd/Casp8/Ripk3/Bax/BakKO 
iBMDMs 













this manuscript N/A 
murine Gsdmd/Bid/Mlkl/Casp3/7/9KO 
iBMDMs 
this manuscript N/A 
murine Gsdmd/Bid/Mlkl/Casp3/6/7/9KO 
iBMDMs 
this manuscript N/A 
murine Gsdmd/Bid/Mlkl/Casp1/3/7/9KO 
iBMDMs 
this manuscript N/A 
Experimental Models: Organisms/Strains 
Mice: C57BL/6 (WT) WEHI N/A 
Mice: MLKL-/-  (Murphy et al., 
2013) 
N/A 
Mice: Casp1/11-/- (Kuida et al., 
1995) 
N/A 
Mice: Casp1/11/12-/- (Salvamoser et al., 
2019) 
N/A 
Mice: Casp1/11/12/Ripk3-/- this manuscript N/A 
Mice: Casp1/11/12/8/Ripk3-/- this manuscript N/A 
Mice: Casp8/Ripk3-/- (Oberst et al., 
2011) 
N/A 
Salmonella Typhimurium: SL1344 ATCC Cat#14028 
Salmonella Typhimurium: ΔAroA (Kupz et al., 2014) N/A 
Salmonella Typhimurium: SL1344 SPI2 
ssaG-GFP+ 




pVSVg plasmid  Addgene Cat# 8454 
pMDLg/pRRE plasmid Addgene Cat# 12251 
pRSV-Rev plasmid Addgene Cat# 12253 
pFH1tUTG- H1-Tet-sgRNA plasmid (Aubrey et al., 
2015) 
N/A 
pFUGW-Cas9mcherry plasmid (Aubrey et al., 
2015) 
N/A 
Forward Primers for Caspase-1 sgRNA: 
5’-ACTTGCAAACATTACTGCTA-3’ 
this manuscript N/A 
Reverse Primers for Caspase-1 sgRNA: 
5’-TAGCAGTAATGTTTGCAAGT-3’ 
this manuscript N/A 
Forward Primers for Caspase-3 sgRNA: 
5’-ATCTCGCTCTGGTACGGATG-3’ 
this manuscript N/A 
Reverse Primers for Caspase-3 sgRNA: 
5’-CATCCGTACCAGAGCGAGAT-3’ 
this manuscript N/A 
Forward Primers for Caspase-6 sgRNA: 
5’-TGGCGTCGTATGCGTAAACG-3’ 
this manuscript N/A 
Reverse Primers for Caspase-6 sgRNA: 
5’-CGTTTACGCATACGACGCCA-3’ 
this manuscript N/A 
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Forward Primers for Caspase-7 sgRNA: 
5’-GCCCACTTATCTGTACCGCA-3’ 
this manuscript N/A 
Reverse Primers for Caspase-7 sgRNA: 
5’-TGCGGTACAGATAAGTGGGC-3’ 
this manuscript N/A 
Forward Primers for Caspase-8 sgRNA: 
5’-TAGCTTCTGGGCATCCTCGA-3’ 
this manuscript N/A 
Reverse Primers for Caspase-8 sgRNA: 
5’-TCGAGGATGCCCAGAAGCTA-3’ 
this manuscript N/A 
Forward Primers for Caspase-9 sgRNA: 
5’-AACTTGAGCACCGATTCCGC-3’ 
this manuscript N/A 
Reverse Primers for Caspase-9 sgRNA: 
5’-GCGGAATCGGTGCTCAAGTT-3’ 
this manuscript N/A 
Forward Primers for Caspase-11 
sgRNA: 
5’- AGCCTTTCGTGTACGGCCAT -3’ 
this manuscript N/A 
Reverse Primers for Caspase-11 
sgRNA: 
5’- ATGGCCGTACACGAAAGGCT -3’ 
this manuscript N/A 
Forward Primers for Caspase-12 
sgRNA: 
5’-TGCGAGTTTCATCCTGAACA-3’ 
this manuscript N/A 
Reverse Primers for Caspase-12 
sgRNA: 
5’-TGTTCAGGATGAAACTCGCA-3’ 
this manuscript N/A 
Forward Primers for Ripk3 sgRNA: 
5’-GGAACCGCTGACGCACCAGT-3’ 
this manuscript N/A 
Reverse Primers for Ripk3 sgRNA: 
5’-ACTGGTGCGTCAGCGGTTCC-3’ 
this manuscript N/A 
Forward Primers for Gsdmd sgRNA: 
5’-CAGAGGCGATCTCATTCCGG-3’ 
this manuscript N/A 
Reverse Primers for Gsdmd sgRNA: 
5’-CCGGAATGAGATCGCCTCTG-3’ 
this manuscript N/A 
Forward Primers for Bid sgRNA: 
5’-GGTCAGCAACGGTTCCGGCC-3’ 
this manuscript N/A 
Reverse Primers for Bid sgRNA: 
5’-GGCCGGAACCGTTGCTGACC-3’ 
this manuscript N/A 
Forward Primers for Mlkl sgRNA: 
5’-TACCCAACACTTTCGGCCTG-3’ 
this manuscript N/A 
Reverse Primers for Mlkl sgRNA: 
5’-CAGGCCGAAAGTGTTGGGTA-3’ 
this manuscript N/A 
Forward Primers for Caspase12 indel 
sequencing: 
5’-TTACAGCCAGGAGGACACAT-3’ 
this manuscript N/A 
Reverse Primers for Caspase12 indel 
sequencing: 
5’-ACAGTCTAAGGGATATGGGG-3’ 
this manuscript N/A 
Software and Algorithms 





Image Lab Version 6.0.0 Bio-Rad laboratories 
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IMARIS Version 9.5 Oxford Instruments - Imaris 




Protein G Sepharose® 4 fastflow GE Healthcare Cat#17-0618-01 
 763 
 764 
CONTACT FOR REAGENT AND RESOURCE SHARING 765 
Lead Contact 766 
Further information and requests for resources and reagents should be directed to and will be 767 
fulfilled by the Lead Contacts, Andreas Strasser (strasser@wehi.edu.au) and Marco Herold 768 
(herold@wehi.edu.au). 769 
 770 
Materials Availability 771 
Unique mouse lines and iBMDM cell lines generated in this study may be obtained (pending 772 
continued availability) from the Lead Contact with a completed Materials Transfer Agreement. 773 
 774 
Data and Code Availability 775 
The published article includes all datasets generated or analyzed during this study. The full 776 
CRISPR/Cas9 whole genome screen dataset supporting the current study may be obtained from 777 
the Lead Contact upon request.  778 
 779 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 780 
Mice 781 
C57BL/6 (WT), Mlkl-/- (Murphy et al., 2013), Casp8/R3-/- (Oberst et al., 2011),  Casp1/11-/- 782 
(Kuida et al., 1995), Casp1/11/12-/- (Salvamoser et al., 2019), Casp1/11/12/R3-/-, and 783 
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Casp1/11/12/8/R3-/- mice were bred and maintained at The Walter and Eliza Hall Institute of 784 
Medical Research Animal Facility. Both age- and sex-matched animals between eight and 785 
fourteen weeks of age were used for in vivo and in vitro studies. All mice were bred and housed 786 
in specific pathogen-free facilities, in a 12-hour light/dark cycle in ventilated cages, with free 787 
acess to chow and water supply ad libitum. All animal experiments were approved by The 788 
Walter and Eliza Hall Institute of Medical Research Animal Ethics Committee and The 789 
University of Melbourne Animal Ethics Committee (AEC 1714194) and were conducted in 790 
accordance with the Prevention of Cruelty to Animals Act (1986) and the Australian National 791 
Health and Medical Research Council Code of Practice for the Care and Use of Animals for 792 
Scientific Purposes (1997). In accordance with the Prevention of Cruelty to Animals Act (1986) 793 
and the Australian National Health and Medical Research Council Code of Practice for the 794 
Care and Use of Animals for Scientific Purposes mice were euthanized at a weight loss of more 795 
than 15%, which is described in here as ‘mouse survival’. 796 
 797 
Bone Marrow Chimeras 798 
Bone marrow chimeras were generated as previously described (Bachem et al., 2019). Briefly, 799 
C57BL/6-CD45.1 mice were lethally irradiated with 2 doses of 550 rad and reconstituted with 800 
5 ´ 106 T-cell-depleted bone marrow cells from Casp1/11/12/8/Ripk3–/– (C57BL/6-CD45.2) 801 
mice. Chimeric mice were allowed to reconstitute for at least 8 weeks before use in 802 
experiments.  803 
 804 
Bone marrow-derived macrophages (BMDMs) 805 
Bone marrow-derived macrophages (BMDMs) were prepared by flushing bone marrow from 806 
femurs and tibiae of both male and female mice, and culturing cells in DMEM supplemented 807 
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with 10% fetal bovine serum (FBS; Sigma-Aldrich), 15% L929-conditioned medium, 100 808 
U/mL penicillin and 100 mg/mL streptomycin for six days in non-tissue culture treated dishes. 809 
 810 
Immortalized bone marrow-derived macrophages (iBMDMs) 811 
C57BL/6 Cre-J2 immortalized bone marrow-derived macrophages (iBMDM) (De Nardo et al., 812 
2018) were passaged in DMEM supplemented with 10% FBS, 100 U/mL penicillin and 813 
100 mg/mL streptomycin at 37°C and 10% CO2. CRISPR/Cas9 mediated gene deletion was 814 
achieved as previously described (Aubrey et al., 2015; Kueh and Herold, 2016). In brief, 815 
sgRNAs targeting the genes of interest were designed in silico and cloned into an inducible 816 
lentiviral expression vector. Lentivirus was generated using 293T cells and 1 × 105 target 817 
iBMDM cells transduced with the respective virus supernatant. Infected cells were expanded 818 
and single cell sorts into tissue culture medium containing 1 μg/mL dox hyclate (to induce 819 
sgRNA expression) (Sigma-Aldrich D9891) performed on eGFP and mCherry expressing 820 
populations using FACSaria flow cytometer. Single cell clones were expanded and gene 821 
deletion confirmed via Western blot analysis of the targeted protein as described above. 822 
 823 
Bacterial Strains for in vivo and in vitro Infection Studies 824 
For in vivo infection, S. Typhimurium ΔAroA was grown shaking at 37ºC in Luria-Bertani (LB) 825 
broth supplemented with 50 µg/mL streptomycin for 16 to 18 h, diluted in PBS and 200 CFU 826 
were injected into the tail vein in a volume of 200 μL. The number of replicating bacteria was 827 
determined by homogenizing organs from infected mice in 5 mL of sterile PBS. The 828 
homogenate was serially diluted and plated onto LB agar plates supplemented with 50 µg/mL 829 
streptomycin. Plates were incubated at 37º C for 24 h.  830 
S. Typhimurium strain SL1344 was used for in vitro infection of primary bone marrow derived 831 
macrophages (BMDMs) and immortalized bone marrow macrophages (iBMDMs). SL1344 832 
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was grown shaking at 37ºC over night in (LB) broth (+50 µg/mL Streptomycin) for 16 to 18 h 833 
and OD600 was determined using a spectrophotometer to calculate multiplicity of infection 834 
(MOI).  For infection, cells were infected with SL1344 at MOI of 50 in serum free and 835 
antibiotic free medium. After 1 h, cells were washed twice with warm PBS and medium 836 
replaced with serum containing Dulbecco’s modified Eagle’s medium DMEM with 50 µg/mL 837 
Gentamycin to prevent growth of extracellular bacteria. 838 
 839 
METHOD DETAILS 840 
Cell Culture  841 
Bone marrow-derived macrophages (BMDMs) were passaged in DMEM supplemented with 842 
10% FBS, 15% L929-conditioned medium, 100 U/mL penicillin and 100 mg/mL streptomycin 843 
at 37°C and 10% CO2. Immortalized bone marrow-derived macrophages (iBMDM) were 844 
passaged in DMEM supplemented with 10% FBS, 100 U/mL penicillin and 100 mg/mL 845 
streptomycin at 37°C and 10% CO2. For experimental assays, cells were seeded into 6- or 96-846 
well plates at a density of 3 × 105 or 2 × 104 cells/well, respectively, in antibiotic-free medium 847 
and rested for 24 h before infection/treatment and downstream analysis as described below. 848 
Lentiviral Infection and CRISPR/Cas9 Mediated Gene Deletion  849 
CRISPR/Cas9 mediated gene deletion was achieved as previously described (Aubrey et al., 850 
2015; Kueh and Herold, 2016). In brief, sgRNAs targeting the genes of interest were designed 851 
in silico and cloned into an inducible lentiviral expression vector. Lentivirus was generated 852 
using 293T cells and 1 × 105 target iBMDM cells transduced with the respective virus 853 
supernatant. Infected cells were expanded and single cell sorts into tissue culture medium 854 
containing 1 μg/mL dox hyclate (to induce sgRNA expression) (Sigma-Aldrich D9891) 855 
performed on eGFP and mCherry expressing populations using FACSaria flow cytometer. 856 
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Single cell clones were expanded and gene deletion confirmed via Western blot analysis of the 857 
targeted protein as described below or in the case of caspase-12 by Sanger sequencing or NGS 858 
as previously described (Aubrey et al 2015) using primers outlined in the Key resources table. 859 
 860 
LDH Release Cell Death Assay 861 
Viability of uninfected, Salmonella-infected and/or inhibitor treated BMDMs and iBMDMs at 862 
the indicated time points was determined using the CytoTox 96® Non-Radioactive 863 
Cytotoxicity Assay (Promega). The percentage of live cells at each time point was calculated 864 
comparing LDH release of surviving cells in Salmonella-infected wells to LDH release of non-865 
infected control cells. 866 
 867 
Western Blotting 868 
To quantify the levels and activation status of a wide range of cell death initiator and effector 869 
molecules upon Salmonella infection, cells were lysed at the indicated time points by scraping 870 
with cell lysis buffer containing 20 mM Tris-HCl, pH 7.5, 135 mM NaCl, 1.5 mM Mg2Cl, 871 
1 mM EGTA, 1% Triton X-100 (Sigma-Aldrich), 10% glycerol, EDTA-free protease inhibitor 872 
tablets (Roche, Basel, Switzerland), and phosphatase inhibitor tablets (Roche). Cell lysates 873 
were rotated at 4°C for 20 min and then clarified at 4°C at 13,000 g for 15 min. Absolute protein 874 
content of clarified lysates was determined by Bradford assay (Bio-Rad, Hercules, CA, USA), 875 
and equal quantities (20–50 μg) of total protein were separated under denaturing and reducing 876 
conditions (with 5% β-mercaptoethanol) using 4–12% SDS-PAGE gels (Life Technologies). 877 
Proteins were transferred onto  nitrocellulose membranes, blocked with either 5% skim milk 878 
(Devondale, Brunswick, Australia) or 5% BSA (for phospho-proteins) in PBS with 0.05% 879 
Tween-20 (PBST) for 1 hr, and detected using the following primary antibodies: rat anti-880 
caspase-11 (WEHI), rat anti-caspase-1 (WEHI), rat anti-MLKL (3H1; available from Merck), 881 
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rabbit anti-phospho S345 MLKL (EPR9515[2]; Abcam, Cambridge, UK), rat anti-caspase-8 882 
(3B10; WEHI), rabbit anti-cleaved caspase-8 (D5B2; Cell Signaling Technology), rabbit anti-883 
RIPK3 (ProSci, Poway, CA, USA), rabbit anti-cleaved caspase-3 (Asp175; Cell Signaling 884 
Technology), rabbit anti-caspase-7 (D2Q3L, Cell Signalling), rabbit anti-caspase-9 (10-1-87, 885 
WEHI), rabbit anti-GSDMD (EPR19828, Abcam), mouse anti-PARP (C2-10, Santa Cruz), rat 886 
anti-BID (2D1-3, WEHI), mouse anti-HSP70 (BRM-22, Sigma Alrich)  and rabbit anti-β-actin-887 
HRP (Cell Signaling Technology). 888 
HRP-conjugated goat antibodies against mouse, rat or rabbit IgG (Southern Biotech, 889 
Birmingham, AL, USA) were applied as a secondary reagent to membranes, which were 890 
subsequently incubated with Amersham ECL Prime Western Blotting Detection Reagent (GE 891 
Healthcare) and imaged using a ChemiDoc Touch Imaging System (Bio-Rad). Densitometry 892 
was performed using Image Lab v.5.2.1 software (Bio-Rad). 893 
 894 
Immunoprecipitation of Activated BAX  895 
To determine BAX activation, 3 × 105 WT and Casp1/11/12/8/R3-/- primary BMDMs or 896 
Casp1/11/12/8/R3KO iBMDMs were left untreated, infected with Salmonella and/or treated 897 
with a combination of BH3-mimetic drugs (2 µM of each BCL-2i  ABT-199, MCL-1i S63845, 898 
BCL-XLi A1331852) for 16 h and cells then solubilized with 1% CHAPS for 30 min on ice. 899 
Lysates were centrifuged at 13,000 g for 5 min and pre-cleared with 25 μL Protein G Sepharose 900 
(Amersham Biosciences). Pre-cleared supernatant was then incubated with antibody (4 μg) of 901 
6A7 anti-BAX antibody (aa113-19, BD Biosciences Cat# 556467, RRID: AB_396430) and 902 
Protein-G Sepharose for 2 h at 4°C. Unbound proteins were collected and the resin washed 903 
with lysis buffer containing up to 0.1% w/v CHAPS. Immunoprecipitated proteins (IP) were 904 
eluted by boiling in SDS-containing sample buffer. Immunoprecipitates and pre-IP samples 905 
were electrophoresed on SDS-PAGE and immunoblotted for BAX (anti-BAX NT). To avoid 906 
signals from immunoglobulin (Ig) light chains in Western blots, Ig heavy chain-specific HRP-907 
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conjugated goat anti-rabbit IgG antibodies (Southern Biotech Cat# 4041-05) were used as 908 
secondary reagent, as previously described (Dengler et al., 2019). 909 
 910 
Treatment of Cells in vitro with BH3 Mimetic Drugs or Etoposide  911 
Primary Casp1/11/12/8/Ripk3–/– BMDMs or WT and Casp1/11/12/8/Ripk3KO iBMDMs were 912 
seeded for LDH assay or BAX activation analysis as indicated above. The following BH3 913 
mimetic drugs were used for the indicated time points at a final concentration of 2 µM: MCL-914 
1i S63845, BCL-2i ABT199, BCL-XLi A1331852. Etoposide (Sigma) was used at a final 915 
concentration of 50 µM. 916 
 917 
Treatment of Cells in vitro with Caspase Inhibitors 918 
Immortalized bone marrow derived macrophages (iBMDM) of the indicated genotypes were 919 
passaged and seeded for LDH release cell death assay or Western blot analysis as indicated 920 
above. After 24 h, cells were either left untreated, pre-treated with the caspase-1 specific 921 
inhibitor VX-765 (20 µM) or the broadspectrum caspase inhibitor Emricasan (20 µM) for 1 h 922 
prior to infection with Salmonella SL1344 (MOI=50) in the presence of inhibitor. After 1 h, 923 
cells were washed twice with warm PBS and fresh medium containing 50 µg/mL Gentamycin 924 
and the respective inhibitor added. At the indicated time points, cells were either harvested for 925 
Western blot analysis or cell death was measured by LDH release.  926 
 927 
Treatment of Cells in vitro with LPS 928 
Immortalized bone marrow derived macrophages (iBMDM) of the indicated genotypes were 929 
passaged and seeded for Western blot analysis as indicated above. After 24 h, cells were either 930 
left untreated or treated with LPS for 4 hours and harvested for Western blot analysis as 931 
described above. 932 
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Treatment of Cells in vitro with the RIPK1 Inhibitor, Nec1s, and/or TNFa plus 933 
Birinapant and Emricasan 934 
Immortalized bone marrow derived macrophages (iBMDM) of the indicated genotypes were 935 
passaged and seeded for LDH release cell death assay as indicated above. After 24 h, iBMDMs 936 
were either left untreated, pre-treated with the RIPK1 specific inhibitor, Nec1s (30 µM), for 1 937 
h prior to infection with Salmonella SL1344 (MOI=50) in the continued presence of Nec1s. 938 
After 1 h, cells were washed twice with warm PBS and fresh medium containing 50 µg/mL 939 
Gentamycin and Nec1s was added. At the indicated time points, cell death was measured by 940 
LDH release. In order to verify effective inhibition of RIPK1 by Nec1s, iBMDMs were treated 941 
with TNFa (100 ng/mL) + Birinapant (1 µM) + Emricasan (20 µM) with or without Nec1s (30 942 
µM) or Nec1s alone (30 µM) and harvested for LDH cell death assay at the indicated time 943 
points.  944 
 945 
Brightfield, Confocal and Lattice Light Sheet Microscopy 946 
For confocal and lattice light sheet microscopy, WT, Casp1/11/12-/- or Casp1/11/12/8/R3-/- 947 
BMDMs were seeded into Nunc microscopy chamber slides at a density of 1 × 105 per well 948 
using DMEM without phenol red. After 24 h, cells were stained with MitoTracker-Deep Red 949 
FM (Thermo) at a final concentration of 50 nM for 30 min, washed twice and infected with 950 
GFP-expressing Salmonella SPi-2 (kind gift of Strugnell lab, Peter Doherty Institute (Hautefort 951 
et al., 2003)) as previously described. After 30 min, cells were again washed twice and fresh 952 
medium containing Gentamycin (50 µg/mL) and PI (25 μg/mL; Sigma-Aldrich) was added. 953 
Cells were imaged at the Centre for Dynamic Imaging, WEHI, using either a Zeiss LSM 980 954 
or a custom-built Lattice light sheet system constructed as outlined in (Chen et al., 2014). 955 
Confocal images were acquired using a 1.2 NA 40x LD-LCI Plan-Apochromat lens (Zeiss) at 956 
a temperature of 37oC at 5% CO2. For lattice light-sheet imaging, illumination at the back 957 
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aperture of the excitation objective was focussed through an annular mask of 0.44 inner NA 958 
and 0.55 outer NA. Fluorescent emission was collected by detection objective (Nikon, CFI Apo 959 
LWD 25XW, 1.1 NA), and detected by sCMOS cameras (Hamamatsu Orca Flash 4.0 v2). 960 
Lattice light sheet images were de-skewed and deconvolved using an interative Richardson-961 
Lucy algorithm before visualization. Images were processed using either Fiji or IMARIS 962 
software packages. 963 
For Brighfield microscopy, and WT, Casp1/11/12KO or Gsdmd/Bid/Mlkl/casp3/7/9KO iBMDM 964 
cells were seeded into Nunc microscopy chamber slides at a density of 1 × 105 per well using 965 
DMEM. Cells were infected with Salmonella SL1344 (MOI=50) as described above and 966 
images taken on a Zeiss LSM 980.  Images were processed using Fiji software package. 967 
 968 
CRISPR/Cas9 Whole Genome Guide RNA Library Screen  969 
293T cells were used to generate lentivirus containing the YUSA mouse full genome sgRNA 970 
library (Koike-Yusa et al., 2014). Gsdmd/Bid/Mlkl/casp3/7/9KO iBMDMs were seeded at a 971 
density of 1 × 106 and lentivirally transduced with the sgRNA library. BFP+ cells were sorted 972 
using a FACSaria, expanded and seeded into 10 flasks at a density of 2 × 106 cells. The next 973 
day, 5 flasks were infected with Salmonella SL1344 (MOI=50) as described in the protocols 974 
above, and 5 flasks were harvested as non-infection control. Infected flasks were washed every 975 
24 h for 3 days in order to remove cell debris and dying cells, and medium containing 976 
Gentamycin replaced respectively. Once surviving cells of each flask had expanded 977 
sufficiently, they were split and re-seeded at a density of 1 × 106 cells for a second round of 978 
infection. The remaining cells were frozen for analysis of guide RNA enrichment by NGS. 979 
This procedure was repeated for a third round. Genomic DNA of harvested cells from control 980 
flasks and Salmonella-infected flasks was extracted using the Qiagen genomic DNA extraction 981 
kit as per the manufacturer’s protocol (Qiagen). For targeted PCR of gDNA Insertion Sites, 982 
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unique primers were used to amplify from the CRISPR backbone vector which surrounds the 983 
guide RNA sequence (Aubrey et al., 2015). Individual infection and control replicates were 984 
amplified in triplicate. The PCR cycling conditions were as follows: 95ºC 2 min, (95ºC 15 sec, 985 
60ºC 15 sec, 72ºC 30 sec) x35 cycles, 72ºC 7 min, 4ºC hold step).  Amplicon size distribution 986 
was ascertained using the Agilent Tapestation D1000 protocol.   When a single band was 987 
observed at 250 bp, the sample was accepted as amplifying the expected target region.  All 988 
reactions from the entire plate were then pooled and the PCR amplicons were bead purified as 989 
previously described.  The quality and integrity of the samples was ascertained as previously 990 
described and the concentration was used to set up the sequencing reaction. Each dual indexed 991 
library plate pool was quantified using the Agilent Tapestation and the Qubit™ RNA assay kit 992 
for Qubit 2.0® Fluorometer (Life Technologies).  The indexed pool was diluted to 12 pM for 993 
sequencing on a MiSeq instrument as per the manufacturer’s instructions.  The 150 cycle kit 994 
was used to generate a single read of sequence.  The fastq sequence output file from the run 995 
was used for analysis. 996 
For analysis, the data were formatted into a matrix such that each row represented an individual 997 
guide RNA and each column a sample. Analyses of these data were then undertaken using the 998 
edgeR (Robinson et al., 2010) software package. Technical replicates were first combined 999 
using edgeR’s sumTechReps function and water control samples removed prior to data 1000 
filtering. Guide RNAs were filtered out if they failed to achieve a count of 10 in at least 5 1001 
samples, leaving 1384 guides for downstream analysis. Following filtering the data was 1002 
normalized using edgeR’s TMM normalization (Robinson and Oshlack, 2010) with singleton 1003 
pairing.  For normalization only a prior count of 10 was added to all observations. This prior 1004 
count was then removed for all other analyses. Differential abundance of guide RNAs between 1005 
the Salmonella-infected and control samples was assessed using edgeR’s likelihood ratio test. 1006 
The false discovery rate (FDR) for this analysis was set at 5%. The mean-difference plot was 1007 
 52 
generated using edgeR’s plotMD function, while the heatmap was created using the pheatmap 1008 
software package. 1009 
 1010 
  1011 
 53 
QUANTIFICATION AND STATISTICAL ANALYSIS 1012 
Prism v8.0  (GraphPad Software, San Diego, CA, USA) was used to perform statistical tests. 1013 
Groups were compared by either unpaired two-tailed t tests for parametric data, or Mann–1014 
Whitney tests for non-parametric data. Survival data were analyzed using log rank (Mantel 1015 
Cox) test. Please refer to the legend of the figures for description of sample size (n) and 1016 
statistical significance. P values were calculated and are indicated as follows: **P<0.005; 1017 
*P<0.05; nsP>0.05=not significant (ns).    1018 
  1019 
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